» Articles » PMID: 22662012

Amphetamine Use and Its Associated Factors in Body Builders: a Study from Tehran, Iran

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2012 Jun 5
PMID 22662012
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Epidemiological studies on all types of illicit drug use among athletes are essential for both the sport community and drug control achievements. Here, we investigated the prevalence and associated factors of amphetamine use in body builders in Tehran, Iran, 2007.

Material And Methods: This study is a secondary analysis of a substance use survey done in 103 randomly selected gymnasia in Tehran (capital city of Iran). The survey was conducted from November 2007 to January 2008 and included 843 randomly selected bodybuilders (aged 40 years or less). By interviews via questionnaires the following data were obtained: age, job, marital status, education level, housing status, average monthly family income, number of family members, gymnasium area (m(2)), number of trainers, number of gymnasium members, initiation time (months), weekly duration of the sporting activity (h), monthly cost of the sporting activity, purpose of participating in sporting activity, and history of anabolic steroid and amphetamine use.

Results: One hundred twenty (13.3%) body builders reported a history of amphetamine use. According to the results of regression analysis, being married (risk ratio - RR = 0.540), and participating in body building to enhance self-esteem (RR = 0.423) or to enhance sport performance (RR = 0.545) had protective effects on amphetamine use. However, having university qualifications (RR = 1.843), using anabolic steroids (RR = 1.803) and participating in sport to maintain fitness (RR = 2.472) were linked to increased risk of amphetamine use.

Conclusions: Well-educated bodybuilders were more likely to use amphetamines, and why this is so needs to be discovered. If further studies show that they are not aware of the dangers associated with amphetamine use, providing them with information should be considered.

Citing Articles

Evaluation of the health status outcome among inpatients treated for Amphetamine Addiction.

Alharbi R, Alhowail A, Alharbi A, Emara A Saudi J Biol Sci. 2022; 29(3):1465-1476.

PMID: 35280559 PMC: 8913373. DOI: 10.1016/j.sjbs.2021.11.025.


Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.

Piacentino D, Sani G, Kotzalidis G, Cappelletti S, Longo L, Rizzato S Hum Psychopharmacol. 2021; 37(1):e2815.

PMID: 34528289 PMC: 8727496. DOI: 10.1002/hup.2815.


Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.

Torrisi M, Pennisi G, Russo I, Amico F, Esposito M, Liberto A Medicina (Kaunas). 2020; 56(11).

PMID: 33158202 PMC: 7694262. DOI: 10.3390/medicina56110587.


Investigating the sequential patterns of methamphetamine use initiation in Iran.

Sarani E, Ahmadi J, Oji B, Mahi-Birjand M, Bagheri N, Bazrafshan A Subst Abuse Treat Prev Policy. 2020; 15(1):52.

PMID: 32727512 PMC: 7392828. DOI: 10.1186/s13011-020-00297-z.


Associations of childhood experiences and methamphetamine use among Akha and Lahu hill tribe youths in northern Thailand: A cross-sectional study.

Apidechkul T, Chomchoei C, Wongnuch P, Tamornpark R, Upala P, Yeemard F PLoS One. 2020; 15(6):e0234923.

PMID: 32555604 PMC: 7302480. DOI: 10.1371/journal.pone.0234923.


References
1.
Challier B, Chau N, Predine R, Choquet M, Legras B . Associations of family environment and individual factors with tobacco, alcohol, and illicit drug use in adolescents. Eur J Epidemiol. 2000; 16(1):33-42. DOI: 10.1023/a:1007644331197. View

2.
Bauman A, Phongsavan P . Epidemiology of substance use in adolescence: prevalence, trends and policy implications. Drug Alcohol Depend. 1999; 55(3):187-207. DOI: 10.1016/s0376-8716(99)00016-2. View

3.
Matano R, Wanat S, Westrup D, Koopman C, Whitsell S . Prevalence of alcohol and drug use in a highly educated workforce. J Behav Health Serv Res. 2002; 29(1):30-44. DOI: 10.1007/BF02287830. View

4.
Lukas S . CNS effects and abuse liability of anabolic-androgenic steroids. Annu Rev Pharmacol Toxicol. 1996; 36:333-57. DOI: 10.1146/annurev.pa.36.040196.002001. View

5.
Moghadamnia A, Abdollahi M . An epidemiological study of poisoning in northern Islamic Republic of Iran. East Mediterr Health J. 2004; 8(1):88-94. View